If patient regular give tab Amlodipine 5mg n suddenly shifted to tab Telmikind.... what s the reaction

Reading File
Finding Sources
Finding Sources
Searching the Web

switching amlodipine to telmisartan abrupt switch reaction blood pressure

Finding Sources
Finding Sources
Reading Web Page

switching amlodipine to telmisartan reaction blood pressure

Reading File
Finding Sources
I now have enough information to give a comprehensive, clinically relevant answer.

Switching Amlodipine 5mg → Telmikind (Telmisartan 40mg): What to Expect

Telmikind is a brand name for Telmisartan 40mg — an Angiotensin Receptor Blocker (ARB). This is a complete class switch from a Calcium Channel Blocker (CCB) to an ARB. Here is exactly what happens:

🔄 Mechanism Comparison

FeatureAmlodipine (CCB)Telmisartan (ARB)
ClassDihydropyridine Calcium Channel BlockerAngiotensin II Receptor Blocker
MechanismBlocks L-type Ca²⁺ channels → vasodilationBlocks AT₁ receptors → prevents Ang II vasoconstriction
Half-life~35–50 hours (very long)~24 hours
Heart rate effectMild reflex tachycardiaNeutral
EdemaYes (ankle/pedal edema common)No

⚡ What Happens After Abrupt Switch

1. No Rebound Hypertension (unlike beta-blockers)

Unlike beta-blockers or clonidine, amlodipine does NOT cause rebound hypertension on abrupt discontinuation. Its very long half-life (~35–50 hrs) means the drug tapers itself off naturally over 2–3 days. No tapering is required.

2. Temporary Blood Pressure Gap

  • Telmisartan takes 1–2 weeks to reach full antihypertensive effect (ARBs need time to establish steady-state neurohormonal blockade).
  • Amlodipine's residual drug will cover the first few days due to its long half-life.
  • However, in the day 3–7 window, there may be a transient rise in BP if telmisartan 40mg is insufficient for that patient.

3. Hemodynamic Shift

  • Amlodipine causes vasodilation via smooth muscle calcium blockade + mild reflex sympathetic activation.
  • Telmisartan works through the RAAS axis. In a patient who was vasodilated on amlodipine, switching may cause mild vasoconstriction temporarily until the ARB's effect is established.

4. Disappearance of Amlodipine-related Side Effects

  • Pedal/ankle edema — will resolve within days (this is often why a switch is made).
  • Reflex tachycardia/flushing — will resolve.

5. New Side Effect Profile with Telmisartan

  • Hyperkalemia risk — especially if the patient has CKD, diabetes, or is on potassium-sparing agents.
  • First-dose hypotension — particularly in volume-depleted patients.
  • Dry cough is NOT expected (that's ACE inhibitors, not ARBs).
  • Angioedema — rare but possible.

⚠️ Clinical Concern: Dose Equivalence

Amlodipine 5mg is a moderate dose CCB. Telmisartan 40mg is a standard starting ARB dose but may not provide equivalent BP control for every patient, especially those with:
  • Isolated systolic hypertension
  • High-salt diet
  • No RAAS activation (where ARBs work best)
If BP was well controlled on Amlodipine 5mg, monitor closely — Telmisartan 40mg may or may not be equivalent for that individual.

✅ Summary

ConcernAnswer
Rebound hypertension?No — amlodipine's long half-life prevents this
Tapering needed?No
BP gap possible?Yes, days 3–10 — monitor BP
Edema resolves?Yes
New side effects?Hyperkalemia, first-dose hypotension
Switch safe?Yes, but monitor BP for 1–2 weeks
Bottom line: The switch is generally safe and does not require tapering. The main clinical risk is a transient BP control gap in the first 1–2 weeks while telmisartan establishes its effect. Monitor BP closely and consider checking electrolytes (K⁺) after 1–2 weeks, especially in patients with CKD or diabetes.
(Katzung's Basic and Clinical Pharmacology, 16th Edition, p. 283)
This is a shared conversation. Sign in to Orris to start your own chat.